# Cost-Effectiveness Analysis of Allopurinol Versus Febuxostat in Chronic Gout Patients: A U.S. Payer Perspective

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-analysis-of-allopurinol-versus-febuxostat-in-chronic-gout/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Pranav Gandhi,William M. Gentry,Qinli Ma,Michael B. Bottorff |
| Citations | 29 |
| DOI | 10.18553/jmcp.2015.21.2.165 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.jmcp.org/doi/pdf/10.18553/jmcp.2015.21.2.165 |
| OpenAlex ID | https://openalex.org/W2304340131 |
| PMID | 25615006 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Pranav Gandhi](https://scholariq.org/researchers/pranav-gandhi/)

## Paper journal

- [Journal of Managed Care & Specialty Pharmacy](https://scholariq.org/journals/journal-of-managed-care-and-specialty-pharmacy/)

## Paper primary topic

- [Gout, Hyperuricemia, Uric Acid](https://scholariq.org/topics/gout-hyperuricemia-uric-acid/)

## Paper topics

- [Gout, Hyperuricemia, Uric Acid](https://scholariq.org/topics/gout-hyperuricemia-uric-acid/)
- [Thyroid Disorders and Treatments](https://scholariq.org/topics/thyroid-disorders-and-treatments/)
- [Inflammasome and immune disorders](https://scholariq.org/topics/inflammasome-and-immune-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.